Workshop: Implementing NGS to quantify human and pathogen tumor markers in plasma and tissue

Published Thu Nov 29, 2018

Watch the presentation


In this talk, Margaret Gulley, MD from the UNC School of Medicine describes her group’s method to quantify cancer mutations alongside tumor-related viral and bacterial pathogens in plasma and FFPE tissue using modified off-the-shelf Archer NGS reagents combined with Archer Analysis bioinformatics. She discusses analytic and clinical interpretation criteria and the value of molecular barcodes and noise reduction algorithms in patient and control DNA.

This presentation was recorded at the Association for Molecular Pathology (AMP) annual meeting in October, 2018.

About the presenter

Margaret Gulley, MD

Margaret Gulley, MD

Dr. Gulley is Director of Molecular Pathology in the Department of Pathology and Laboratory Medicine at the University of North Carolina Chapel Hill School of Medicine.

How to contact us


2477 55th Street, Suite 202

Boulder, CO 80301


Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2018 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.